Chlorogenic Acid: Recent advances on its dual role as a food additive and a nutraceutical against metabolic syndrome

Molecules

Volumn 22, Issue 3, 2017, Pages

  Santana Gálvez, Jesús ^a   Cisneros Zevallos, Luis ^b   Jacobo Velázquez, Daniel A ^a  

^a SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

5 O caffeoylquinic acid; Antibiotic; Antioxidant; Chlorogenic acid; Metabolic syndrome; Prebiotic

Indexed keywords

5'-O-CAFFEOYLQUINIC ACID; CHLOROGENIC ACID; FOOD ADDITIVE; QUINIC ACID;

ANALOGS AND DERIVATIVES; ANIMAL; CLINICAL TRIAL (TOPIC); DIET THERAPY; DIETARY SUPPLEMENT; DISEASE MODEL; HUMAN; METABOLIC SYNDROME X; TREATMENT OUTCOME;

ANIMALS; CHLOROGENIC ACID; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FOOD ADDITIVES; HUMANS; METABOLIC SYNDROME X; QUINIC ACID; TREATMENT OUTCOME;

EID: 85014542454     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22030358     Document Type: Review

References (81)

1. Naso, L.G.; Valcarcel, M.; Roura-Ferrer, M.; Kortazar, D.; Salado, C.; Lezama, L.; Rojo, T.; González-Baró, A.C.; Williams, P.A.M.; Ferrer, E.G. Promising antioxidant and anticancer (human breast cancer) oxidovanadium(IV) complex of chlorogenic acid. Synthesis, characterization and spectroscopic examination on the transport mechanism with bovine serum albumin. J. Inorg. Biochem. 2014, 135, 86-99. [CrossRef] [PubMed]
2. Wang, L.-N.; Wang, W.; Hattori, M.; Daneshtalab, M.; Ma, C.-M. Synthesis, anti-HCV, antioxidant and reduction of intracellular reactive oxygen species generation of a chlorogenic acid analogue with an amide bond replacing the ester bond. Molecules 2016, 21, 737. [CrossRef] [PubMed]
3. Kremr, D.; Bajer, T.; Bajerová, P.; Surmová, S.; Ventura, K. Unremitting problems with chlorogenic acid nomenclature: A review. Quím. Nova 2016, 39, 530-533. [CrossRef]
4. International Union of Pure and Applied Chemistry (IUPAC). Commission on the Nomenclature of Organic Chemistry (CNOC); IUPAC-IUB Commission on Biochemical Nomenclature (CBN). Biochem. J. 1976, 153, 23.
5. Niggeweg, R.; Michael, A.J.; Martin, C. Engineering plants with increased levels of the antioxidant chlorogenic acid. Nat. Biotechnol. 2004, 22, 746-754. [CrossRef] [PubMed]
6. Zhao, M.; Wang, H.; Yang, B.; Tao, H. Identification of cyclodextrin inclusion complex of chlorogenic acid and its antimicrobial activity. Food Chem. 2010, 120, 1138-1142. [CrossRef]
7. Luo, H.-J.; Wang, J.-Z.; Chen, J.-F.; Zou, K. Docking study on chlorogenic acid as a potential H5N1 influenza A virus neuraminidase inhibitor. Med. Chem. Res. 2011, 20, 554-557. [CrossRef]
8. Karunanidhi, A.; Thomas, R.; van Belkum, A.; Neela, V. In vitro antibacterial and antibiofilm activities of chlorogenic acid against clinical isolates of Stenotrophomonas maltophilia including the trimethoprim/ sulfamethoxazole resistant strain. Biomed. Res. Int. 2013, 2013, 392058. [CrossRef] [PubMed]
9. Li, G.; Wang, X.; Xu, Y.; Zhang, B.; Xia, X. Antimicrobial effect and mode of action of chlorogenic acid on Staphylococcus aureus. Eur. Food Res. Technol. 2014, 238, 589-596. [CrossRef]
10. Vereshchagina, Y.V.; Bulgakov, V.P.; Grigorchuk, V.P.; Rybin, V.G.; Veremeichik, G.N.; Tchernoded, G.K.; Gorpenchenko, T.Y.; Koren, O.G.; Phan, N.H.T.; Minh, N.T.; et al. The rolC gene increases caffeoylquinic acid production in transformed artichoke cells. Appl. Microbiol. Biotechnol. 2014, 98, 7773-7780. [CrossRef] [PubMed]
11. Bhattacharyya, S.; Majhi, S.; Saha, B.P.; Mukherjee, P.K. Chlorogenic acid-phospholipid complex improve protection against UVA induced oxidative stress. J. Photochem. Photobiol. B 2014, 130, 293-298. [CrossRef] [PubMed]
12. Lou, Z.; Wang, H.; Zhu, S.; Ma, C.; Wang, Z. Antibacterial activity and mechanism of action of chlorogenic acid. J. Food Sci. 2011, 76, M398-M403. [CrossRef] [PubMed]
13. Jacobo-Velázquez, D.A.; Martínez-Hernández, G.B.; Rodríguez, S.C.; Cao, C.-M.; Cisneros-Zevallos, L. Plants as biofactories: Physiological role of reactive oxygen species on the accumulation of phenolic antioxidants in carrot tissue under wounding and hyperoxia stress. J. Agric. Food Chem. 2011, 59, 6583-6593. [CrossRef] [PubMed]
14. Becerra-Moreno, A.; Redondo-Gil, M.; Benavides, J.; Nair, V.; Cisneros-Zevallos, L.; Jacobo-Velázquez, D.A. Combined effect of water loss and wounding stress on gene activation of metabolic pathways associated with phenolic biosynthesis in carrot. Front. Plant Sci. 2015, 6, 1-15. [CrossRef] [PubMed]
15. Santana-Gálvez, J.; Pérez-Carrillo, E.; Velázquez-Reyes, H.H.; Cisneros-Zevallos, L.; Jacobo-Velázquez, D.A. Application of wounding stress to produce a nutraceutical-rich carrot powder ingredient and its incorporation to nixtamalized corn flour tortillas. J. Funct. Foods 2016, 27, 655-666. [CrossRef]
16. Jin, S.; Chang, C.; Zhang, L.; Liu, Y.; Huang, X.; Chen, Z. Chlorogenic acid improves late diabetes through adiponectin receptor signaling pathways in db/db mice. PLoS ONE 2015, 10, e0120842. [CrossRef] [PubMed]
17. Torres-Contreras, A.M.; Nair, V.; Cisneros-Zevallos, L.; Jacobo-Velázquez, D.A. Effect of exogenous amylolytic enzymes on the accumulation of chlorogenic acid isomers in wounded potato tubers. J. Agric. Food Chem. 2014, 62, 7671-7675. [CrossRef] [PubMed]
18. Torres-Contreras, A.M.; Nair, V.; Cisneros-Zevallos, L.; Jacobo-Velázquez, D.A. Plants as biofactories: Stress-induced production of chlorogenic acid isomers in potato tubers as affected by wounding intensity and storage time. Ind. Crops Prod. 2014, 62, 61-66. [CrossRef]
19. Fiamegos, Y.C.; Kastritis, P.L.; Exarchou, V.; Han, H.; Bonvin, A.M.J.J.; Vervoort, J.; Lewis, K.; Hamblin, M.R.; Tegos, G.P. Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against Gram-positive pathogenic bacteria. PLoS ONE 2011, 6, e18127. [CrossRef] [PubMed]
20. Liang, N.; Kitts, D.D. Role of chlorogenic acids in controlling oxidative and inflammatory stress conditions. Nutrients 2016, 8, 16. [CrossRef] [PubMed]
21. Jiang, Y.; Kusama, K.; Satoh, K.; Takayama, F.; Watanabe, S.; Sakagami, H. Induction of cytotoxicity by chlorogenic acid in human oral tumor cell lines. Phytomedicine 2000, 7, 483-491. [CrossRef]
22. Yagasaki, K.; Miura, Y.; Okauchi, R.; Furuse, T. Inhibitory effects of chlorogenic acid and its related compounds on the invasion of hepatoma cells in culture. Cytotechnology 2000, 33, 229-235. [CrossRef] [PubMed]
23. Belkaid, A.; Currie, J.C.; Desgagnés, J.; Annabi, B. The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression. Cancer Cell Int. 2006, 6, 7. [CrossRef] [PubMed]
24. Noratto, G.; Porter, W.; Byrne, D.; Cisneros-Zevallos, L. Identifying peach and plum polyphenols with chemopreventive potential against estrogen-independent breast cancer cells. J. Agric. Food Chem. 2009, 57, 5219-5226. [CrossRef] [PubMed]
25. Liu, Y.J.; Zhou, C.Y.; Qiu, C.H.; Lu, X.M.; Wang, Y.T. Chlorogenic acid induced apoptosis and inhibition of proliferation in human acute promyelocytic leukemia HL-60 cells. Mol. Med. Rep. 2013, 8, 1106-1110. [CrossRef] [PubMed]
26. Meng, S.; Cao, J.; Feng, Q.; Peng, J.; Hu, Y. Roles of chlorogenic acid on regulating glucose and lipids metabolism: A review. Evid. Based Complement. Alternat. Med. 2013, 2013, 801457. [CrossRef] [PubMed]
27. Zhao, Y.; Wang, J.; Ballevre, O.; Luo, H.; Zhang, W. Antihypertensive effects and mechanisms of chlorogenic acids. Hypertens. Res. 2012, 35, 370-374. [CrossRef] [PubMed]
28. Lee, K.; Lee, J.-S.; Jang, H.-J.; Kim, S.-M.; Chang, M.S.; Park, S.H.; Kim, K.S.; Bae, J.; Park, J.-W.; Lee, B.; et al. Chlorogenic acid ameliorates brain damage and edema by inhibiting matrix metalloproteinase-2 and 9 in a rat model of focal cerebral ischemia. Eur. J. Pharmacol. 2012, 689, 89-95. [CrossRef] [PubMed]
29. Aseervatham, G.S.B.; Suryakala, U.; Doulethunisha; Sundaram, S.; Bose, P.C.; Sivasudha, T. Expression pattern of NMDA receptors reveals antiepileptic potential of apigenin 8-C-glucoside and chlorogenic acid in pilocarpine induced epileptic mice. Biomed. Pharmacother. 2016, 82, 54-64. [CrossRef] [PubMed]
30. Dhingra, D.; Gahalain, N. Reversal of reserpine-induced orofacial dyskinesia by chlorogenic acid in rats. Pharmacologia 2016, 7, 272-277. [CrossRef]
31. Kaur, J. A comprehensive review on metabolic syndrome. Cardiol. Res. Pract. 2014, 2014, 943162. [CrossRef] [PubMed]
32. International Diabetes Federation (IDF). IDF Worldwide Definition of the Metabolic Syndrome. Available online: http://www.idf.org/metabolic-syndrome (accessed on 1 December 2016).
33. Kassi, E.; Pervanidou, P.; Kaltsas, G.; Chrousos, G. Metabolic syndrome: Definitions and controversies. BMC Med. 2011, 9, 48. [CrossRef] [PubMed]
34. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 2004, 114, 1752-1761. [CrossRef] [PubMed]
35. Patti, A.M.; Al-Rasadi, K.; Katsiki, N.; Banerjee, Y.; Nikolic, D.; Vanella, L.; Giglio, R.V.; Giannone, V.A.; Montalto, G.; Rizzo, M. Effect of a natural supplement containing Curcuma longa, guggul, and chlorogenic acid in patients with metabolic syndrome. Angiology 2015, 66, 856-861. [CrossRef] [PubMed]
36. Cho, A.S.; Jeon, S.M.; Kim, M.J.; Yeo, J.; Seo, K.I.; Choi, M.S.; Lee, M.K. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem. Toxicol. 2010, 48, 937-943. [CrossRef] [PubMed]
37. Huang, K.; Liang, X.-C.; Zhong, Y.-L.; He, W.-Y.; Wang, Z. 5-Caffeoylquinic acid decreases diet-induced obesity in rats by modulating PPARα and LXRα transcription. J. Sci. Food Agric. 2015, 95, 1903-1910. [CrossRef] [PubMed]
38. Wan, C.-W.; Wong, C.N.-Y.; Pin, W.-K.; Wong, M.H.-Y.; Kwok, C.-Y.; Chan, R.Y.-K.; Yu, P.H.-F.; Chan, S.-W. Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemic rats induced with a high-cholesterol diet. Phytother. Res. 2013, 27, 545-551. [CrossRef] [PubMed]
39. Ong, K.W.; Hsu, A.; Tan, B.K.H. Antidiabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation. Biochem. Pharmacol. 2013, 85, 1341-1351. [CrossRef] [PubMed]
40. Hunyadi, A.; Martins, A.; Hsieh, T.-J.; Seres, A.; Zupkó, I. Chlorogenic acid and rutin play a major role in the in vivo antidiabetic activity of Morus alba leaf extract on type II diabetic rats. PLoS ONE 2012, 7, e50619. [CrossRef] [PubMed]
41. Kim, C.-S.; Kim, J.; Lee, Y.M.; Sohn, E.; Jo, K.; Kim, J.S. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats. Arch. Pharm. Res. 2011, 34, 847-852. [CrossRef] [PubMed]
42. Bagdas, D.; Etoz, B.C.; Gul, Z.; Ziyanok, S.; Inan, S.; Turacozen, O.; Gul, N.Y.; Topal, A.; Cinkilic, N.; Tas, S.; et al. In vivo systemic chlorogenic acid therapy under diabetic conditions: Wound healing effects and cytotoxicity/genotoxicity profile. Food Chem. Toxicol. 2015, 81, 54-61. [CrossRef] [PubMed]
43. Suzuki, A.; Yamamoto, N.; Jokura, H.; Yamamoto, M.; Fujii, A.; Tokimitsu, I.; Saito, I. Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats. J. Hypertens. 2006, 24, 1065-1073. [CrossRef] [PubMed]
44. Ma, Y.; Gao, M.; Liu, D. Chlorogenic acid improves high fat diet-induced hepatic steatosis and insulin resistance in mice. Pharm. Res. 2015, 32, 1200-1209. [CrossRef] [PubMed]
45. Thom, E. The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people. J. Int. Med. Res. 2007, 35, 900-908. [CrossRef] [PubMed]
46. Soga, S.; Ota, N.; Shimotoyodome, A. Stimulation of postprandial fat utilization in healthy humans by daily consumption of chlorogenic acids. Biosci. Biotechnol. Biochem. 2013, 77, 1633-1636. [CrossRef] [PubMed]
47. Van Dijk, A.E.; Olthof, M.R.; Meeuse, J.C.; Seebus, E.; Heine, R.J.; van Dam, R.M. Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 2009, 32, 1023-1025. [CrossRef] [PubMed]
48. Johnston, K.L.; Clifford, M.N.; Morgan, L.M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: Glycemic effects of chlorogenic acid and caffeine. Am. J. Clin. Nutr. 2003, 78, 728-733. [PubMed]
49. Iwai, K.; Narita, Y.; Fukunaga, T.; Nakagiri, O.; Kamiya, T.; Ikeguchi, M.; Kikuchi, Y. Study on the postprandial glucose responses to a chlorogenic acid-rich extract of decaffeinated green coffee beans in rats and healthy human subjects. Food Sci. Technol. Res. 2012, 18, 849-860. [CrossRef]
50. Ahrens, M.J.; Thompson, D.L. Effect of emulin on blood glucose in type 2 diabetics. J. Med. Food 2013, 16, 1-6. [CrossRef] [PubMed]
51. Mubarak, A.; Bondonno, C.P.; Liu, A.H.; Considine, M.J.; Rich, L.; Mas, E.; Croft, K.D.; Hodgson, J.M. Acute effects of chlorogenic acid on nitric oxide status, endothelial function, and blood pressure in healthy volunteers: A randomized trial. J. Agric. Food Chem. 2012, 60, 9130-9136. [CrossRef] [PubMed]
52. Ward, N.C.; Hodgson, J.M.; Woodman, R.J.; Zimmermann, D.; Poquet, L.; Leveques, A.; Actis-Goretta, L.; Puddey, I.B.; Croft, K.D. Acute effects of chlorogenic acids on endothelial function and blood pressure in healthy men and women. Food Funct. 2016, 7, 2197-2203. [CrossRef] [PubMed]
53. Kozuma, K.; Tsuchiya, S.; Kohori, J.; Hase, T.; Tokimitsu, I. Antihypertensive effect of green coffee bean extract on mildly hypertensive subjects. Hypertens. Res. 2005, 28, 711-718. [CrossRef] [PubMed]
54. Watanabe, T.; Arai, Y.; Mitsui, Y.; Kusaura, T.; Okawa, W.; Kajihara, Y.; Saito, I. The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin. Exp. Hypertens. 2006, 28, 439-449. [CrossRef] [PubMed]
55. Jacobo-Velázquez, D.A.; Ortega-Hernández, E.; Cisneros-Zevallos, L. Vegetable-containing juices (carrot, kale and sprout). In Handbook of Functional Beverages and Human Health; Shahidi, F., Alasalvar, C., Eds.; CRC Press Taylor & Francis Group: Boca Raton, FL, USA, 2016; pp. 609-626.
56. Osorio, C.; Schreckinger, E.; Bhargava, P.; Bang, W.Y.; Jacobo-Velázquez, D.A.; Cisneros-Zevallos, L. Golden berry and selected tropical (açai, acerola and maqui) juices. In Handbook of Functional Beverages and Human Health; Shahidi, F., Alasalvar, C., Eds.; CRC Press Taylor & Francis Group: Boca Raton, FL, USA, 2016; pp. 251-269.
57. Monteiro, R.; Azevedo, I. Chronic inflammation in obesity and the metabolic syndrome. Mediat. Inflamm. 2010, 2010, 289645. [CrossRef] [PubMed]
58. Olthof, M.R.; Hollman, P.C.; Katan, M.B. Chlorogenic acid and caffeic acid are absorbed in humans. J. Nutr. 2001, 131, 66-71. [PubMed]
59. Prabha, P.S.; Das, U.N.; Koratkar, R.; Sagar, P.S.; Ramesh, G. Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot. Essent. Fatty Acids 1990, 41, 27-33. [CrossRef]
60. Redón, J.; Oliva, M.R.; Tormos, C.; Giner, V.; Chaves, J.; Iradi, A.; Sáez, G.T. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003, 41, 1096-1101. [CrossRef] [PubMed]
61. Thomas, G.D.; Zhang, W.; Victor, R.G. Nitric oxide deficiency as a cause of clinical hypertension: Promising new drug targets for refractory hypertension. JAMA 2001, 285, 2055-2057. [CrossRef] [PubMed]
62. Mullan, B.A.; Young, I.S.; Fee, H.; MaCance, D.R. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 2002, 40, 804-809. [CrossRef] [PubMed]
63. Taddei, S.; Virdis, A.; Ghiadoni, L.; Magagna, A.; Salvetti, A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998, 97, 2222-2229. [CrossRef] [PubMed]
64. Olthof, M.R.; Hollman, P.C.H.; Buijsman, M.N.C.P.; van Amelsvoort, J.M.M.; Katan, M.B. Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J. Nutr. 2003, 33, 1806-1814.
65. Toda, S.; Kumura, M.; Ohnishi, M. Effects of phenolcarboxylic acids on superoxide anion and lipid peroxidation induced by superoxide anion. Planta Med. 1991, 57, 8-10. [CrossRef] [PubMed]
66. Suzuki, A.; Kagawa, D.; Fujii, A.; Ochiai, R.; Tokimitsu, I.; Saito, I. Short-and long-term effects of ferulic acid on blood pressure in spontaneously hypertensive rats. Am. J. Hypertens. 2002, 15, 351-357. [CrossRef]
67. Muthuswamy, S.; Vasantha-Rupasinghe, H.P. Fruit phenolics as natural antimicrobial agents: Selective antimicrobial activity of catechin, chlorogenic acid and phloridzin. J. Food Agric. Environ. 2007, 5, 81-85.
68. Bajko, E.; Kalinowska, M.; Borowski, P.; Siergiejczyk, L. 5-O-Caffeoylquinic acid: A spectroscopic study and biological screening for antimicrobial activity. Food Sci. Technol. 2016, 65, 471-479. [CrossRef]
69. Puupponen-Pimiä, R.; Nohynek, L.; Meier, C.; Kähkönen, M.; Heinonen, M.; Hopia, A.; Oksman-Caldentey, K.-M. Antimicrobial properties of phenolic compounds from berries. J. Appl. Microbiol. 2001, 90, 494-507. [CrossRef] [PubMed]
70. Luis, A.; Silva, F.; Sousa, S.; Duarte, A.P.; Domingues, F. Antistaphylococcal and biofilm inhibitory activities of Gallic, caffeic, and chlorogenic acids. Biofouling 2014, 30, 69-79. [CrossRef] [PubMed]
71. Sung, W.S.; Lee, D.G. Antifungal action of chlorogenic acid against pathogenic fungi, mediated by membrane disruption. Pure Appl. Chem. 2010, 82, 219-226. [CrossRef]
72. Li, X.; Liu, Y.; Hou, X.; Peng, H.; Zhang, L.; Jiang, Q.; Shi, M.; Ji, Y.; Wang, Y.; Shi, W. Chlorogenic acid inhibits the replication and viability of enterovirus 71 in vitro. PLoS ONE 2013, 8, e76007. [CrossRef] [PubMed]
73. Wang, G.F.; Shi, L.P.; Ren, Y.D.; Liu, Q.F.; Liu, H.F.; Zhang, R.J.; Li, Z.; Zhu, F.H.; He, P.L.; Tang, W.; et al. Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. Antivir. Res. 2009, 83, 186-190. [CrossRef] [PubMed]
74. Mahboob, T.; Azlan, A.-M.; Tan, T.-C.; Samudi, C.; Sekaran, S.D.; Nissapatorn, V.; Wiart, C. Anti-encystment and amoebicidal activity of Lonicera japonica Thunb. and its major constituent chlorogenic acid in vitro. Asian Pac. J. Trop. Med. 2016, 9, 866-871. [CrossRef] [PubMed]
75. Laguerre, M.; Chen, B.; Lecomte, J.; Villeneuve, P.; McClements, D.J.; Decker, E.A. Antioxidant properties of chlorogenic acid and its alkyl esters in stripped corn oil in combination with phospholipids and/or water. J. Agric. Food Chem. 2011, 59, 10361-10366. [CrossRef] [PubMed]
76. Laguerre, M.; López-Giraldo, L.J.; Lecomte, J.; Figueroa-Espinoza, M.C.; Baréa, B.; Weiss, J.; Decker, E.A.; Villeneuve, P. Chain length affects antioxidant properties of chlorogenate esters in emulsion: The cutoff theory behind the polar paradox. J. Agric. Food Chem. 2009, 57, 11335-11342. [CrossRef] [PubMed]
77. Sasaki, K.; Alamed, J.; Weiss, J.; Villeneuve, P.; López-Girlado, L.J.; Lecomte, J.; Figueroa-Espinoza, M.C.; Decker, E.A. Relationship between the physical properties of chlorogenic acid esters and their ability to inhibit lipid oxidation in oil-in-water emulsions. Food Chem. 2010, 118, 830-835. [CrossRef]
78. Kopjar, M.; Jakšić, K.; Piližota, V. Influence of sugars and chlorogenic acid addition on anthocyanin content, antioxidant activity and color of blackberry juice during storage. J. Food Process. Preserv. 2012, 36, 545-552. [CrossRef]
79. Mills, C.E.; Tzounis, X.; Oruna-Concha, M.-J.; Mottram, D.S.; Gibson, G.R.; Spencer, J.P.E. In vitro colonic metabolism of coffee and chlorogenic acid results in selective changes in human faecal microbiota growth. Br. J. Nutr. 2015, 113, 1220-1227. [CrossRef] [PubMed]
80. Santos, R.M.M.; Lima, D.R.A. Coffee consumption, obesity and type 2 diabetes: A mini-review. Eur. J. Nutr. 2016, 55, 1345-1358. [CrossRef] [PubMed]
81. Sánchez-Rangel, J.C.; Jacobo-Velázquez, D.A.; Cisneros-Zevallos, L.; Benavides, J. Primary recovery of bioactive compounds from stressed carrot tissue using aqueous two-phase systems strategies. J. Chem.